It has been reported that IL-2 and retinoic acid (RA) can promote the induction of antigen-specific type 1 Treg (Tr1) cells in EAU, suggesting that IL-2 might be a promising agent for the treatment of uveitis [139]. This evidence concerns the gene IL2 and rheumatoid arthritis.